Therapeutic strategy of targeting epigenetic crosstalk for EZH2-aberrant solid tumors

• 来源期刊: 中国科学基金（英文版）
• 年，卷（期）: 2018,（4）
• 页码范围: 12
• 页数: 1页
• 语种: 英文

摘要

With the support by the National Natural Science Foundation of China and the Chinese Academy of Sciences,the team led by Geng MeiYu (耿美玉),Ding Jian and Tan MinJia at Shanghai Institute of Materia Medica (SIMM),Chinese Academy of Sciences revealed the mechanisms that essentially determine the therapeutic response to EZH2 inhibitors and proposed therapeutic solutions for EZH2-aberrant solid tumors,which was published in Cell (2018,175(1):186-199)